Greg Trottier

1.0k total citations
31 papers, 772 citations indexed

About

Greg Trottier is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Greg Trottier has authored 31 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Greg Trottier's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Greg Trottier is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Greg Trottier collaborates with scholars based in Canada, Australia and Netherlands. Greg Trottier's co-authors include Neil Fleshner, Rodger Loutzenhiser, Nathan Lawrentschuk, Lisa Chilton, Peter J. Boström, Alexandre R. Zlotta, Antonio Finelli, Theodorus van der Kwast, Andrew Evans and Michael A.S. Jewett and has published in prestigious journals such as The Journal of Urology, British Journal of Pharmacology and European Urology.

In The Last Decade

Greg Trottier

29 papers receiving 756 citations

Peers

Greg Trottier
Greg Trottier
Citations per year, relative to Greg Trottier Greg Trottier (= 1×) peers Heinz Voeller

Countries citing papers authored by Greg Trottier

Since Specialization
Citations

This map shows the geographic impact of Greg Trottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Trottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Trottier more than expected).

Fields of papers citing papers by Greg Trottier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Trottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Trottier. The network helps show where Greg Trottier may publish in the future.

Co-authorship network of co-authors of Greg Trottier

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Trottier. A scholar is included among the top collaborators of Greg Trottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Trottier. Greg Trottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhindi, Bimal, David Margel, Robert J. Hamilton, et al.. (2014). The Impact of the Use of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs on the Risk of Prostate Cancer Detection on Biopsy. Urology. 84(5). 1073–1080. 1 indexed citations
2.
Wong, Lih‐Ming, Shabbir M.H. Alibhai, A. Evans, et al.. (2014). Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer. Prostate Cancer and Prostatic Diseases. 18(1). 69–74. 6 indexed citations
3.
Kader, A. Karim, Michael A. Liss, Greg Trottier, et al.. (2014). Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk. Urology. 85(1). 165–171. 1 indexed citations
4.
Wong, Lih‐Ming, Ants Toi, Theodorus van der Kwast, et al.. (2014). Regular Transition Zone Biopsy during Active Surveillance for Prostate Cancer May Improve Detection of Pathological Progression. The Journal of Urology. 192(4). 1088–1093. 6 indexed citations
5.
Bhindi, Bimal, David Margel, Greg Trottier, et al.. (2013). Obesity Is Associated With Larger Prostate Volume but not With Worse Urinary Symptoms: Analysis of a Large Multiethnic Cohort. Urology. 83(1). 81–87. 22 indexed citations
6.
Wong, Lih‐Ming, Shabbir M.H. Alibhai, Greg Trottier, et al.. (2013). A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression. European Urology. 66(3). 406–413. 34 indexed citations
7.
Bhindi, Bimal, Greg Trottier, Malik Elharram, et al.. (2012). Measurement of peri‐prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer. British Journal of Urology. 110(7). 980–986. 46 indexed citations
8.
Yoshimoto, Maisa, Keyue Ding, Joan Sweet, et al.. (2012). PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade. Modern Pathology. 26(3). 435–447. 58 indexed citations
9.
MacLellan, Dawn L., Alan A. Doucette, Greg Trottier, et al.. (2011). Alterations in urinary metabolites due to unilateral ureteral obstruction in a rodent model. Molecular BioSystems. 7(7). 2181–2188. 16 indexed citations
10.
Mason, Ross, Mohamed Abdolell, Greg Trottier, et al.. (2011). Growth Kinetics of Renal Masses: Analysis of a Prospective Cohort of Patients Undergoing Active Surveillance. European Urology. 59(5). 863–867. 121 indexed citations
11.
Boström, Peter J., Sultan Alkhateeb, Greg Trottier, et al.. (2011). Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. British Journal of Urology. 109(1). 70–76. 23 indexed citations
12.
Trottier, Greg, Monique J. Roobol, Nathan Lawrentschuk, et al.. (2011). Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort. British Journal of Urology. 108(8b). E237–44. 55 indexed citations
13.
Lawrentschuk, Nathan, et al.. (2011). An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer. British Journal of Urology. 108(8b). E190–5. 14 indexed citations
14.
Trottier, Greg, Nathan Lawrentschuk, & Neil Fleshner. (2010). Prevention Strategies in Prostate Cancer. Current Oncology. 17(12). 4–10. 10 indexed citations
15.
Lawrentschuk, Nathan, Greg Trottier, Cynthia Kuk, & Alexandre R. Zlotta. (2010). Role of Surgery in High-Risk Localized Prostate Cancer. Current Oncology. 17(12). 25–32. 24 indexed citations
16.
Finelli, Antonio, Greg Trottier, Nathan Lawrentschuk, et al.. (2010). Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer. European Urology. 59(4). 509–514. 40 indexed citations
17.
Kakiashvili, David, Bas W.G. van Rhijn, Greg Trottier, et al.. (2010). Long‐term follow‐up of T1 high‐grade bladder cancer after intravesical bacille Calmette‐Guérin treatment. British Journal of Urology. 107(4). 540–546. 29 indexed citations
18.
Trottier, Greg, Peter J. Boström, Nathan Lawrentschuk, & Neil Fleshner. (2009). Nutraceuticals and prostate cancer prevention: a current review. Nature Reviews Urology. 7(1). 21–30. 82 indexed citations
19.
Trottier, Greg, et al.. (1998). Cyclic GMP‐dependent and cyclic GMP‐independent actions of nitric oxide on the renal afferent arteriole. British Journal of Pharmacology. 125(3). 563–569. 30 indexed citations
20.
Loutzenhiser, Rodger, Lisa Chilton, & Greg Trottier. (1997). Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II. American Journal of Physiology-Renal Physiology. 273(2). F307–F314. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026